Related Experiment Video
Updated: Apr 26, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Assessing the impact of multidrug-resistant tuberculosis in children: an exploratory qualitative study
Caroline Franck1, James A Seddon, Anneke C Hesseling
1Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK. caroline.franck@ladydavis.ca.
Insights
Multidrug-resistant tuberculosis (MDR-TB) treatment significantly impacts children and families psychologically, academically, and financially. Psychosocial support is crucial to manage stigma and chronic illness stressors for pediatric MDR-TB patients.
Area of Science:
- Pediatric infectious diseases
- Public health
- Psychology
Background:
- High prevalence of multidrug-resistant tuberculosis (MDR-TB) in children in the Western Cape, South Africa.
- Limited understanding of the psychosocial impact of MDR-TB treatment on affected children.
Purpose of the Study:
- To explore the individual, familial, and social impacts of MDR-TB and its treatment on children.
- To identify challenges and support needs for pediatric MDR-TB patients and their caregivers.
Main Methods:
- Semi-structured interviews with 20 children and caregivers from a clinical cohort.
- Stratified sampling by age group (children >10 years and 5-10 years).
- Grounded theory analysis of qualitative data.
Main Results:
- Medication side effects and pill burden caused physical, psychological, and academic distress, hindering treatment adherence.
- Younger children showed no lasting effects, but some older children experienced internalized stigma.
- Caregivers faced financial and psychological burdens; community support and social networks fostered resilience.
Conclusions:
- Childhood MDR-TB treatment imposes significant psychological, academic, and financial burdens on children and families.
- Essential to provide psychosocial support to mitigate stigma and manage chronic illness stressors.
- Addressing the holistic needs of pediatric MDR-TB patients is critical for successful outcomes.
Background:
While the prevalence of multidrug-resistant (MDR) tuberculosis (TB) is high among children in the Western Cape of South Africa, the psychosocial implications of treatment for children with MDR-TB remain poorly understood. We sought to explore how MDR-TB and its treatment impact children on an individual, familial, and social level.
Methods:
Semi-structured interviews were conducted with 20 children and caregivers purposively sampled from a prospective clinical cohort of children. The sample was stratified by age at the start of treatment (children >10 years, and 5-10 years). Caregiver proxy interviews were conducted with younger children, supplemented with child interviews; older children were interviewed directly, supplemented with caregiver proxy interviews. Data were analysed using grounded theory.
Results:
Findings revealed pill volume and adverse effects produced significant physical, psychological and academic disturbances in children. Adverse effects related to the medication were important obstacles to treatment adherence. While there appear to be no long-lasting effects in younger children, a few older children showed evidence of persisting internalised stigma. Caregivers suffered important treatment-related financial and psychological costs. Community support, notably through the continued involvement of children in strong social networks, promoted resilience among children and their families.
Conclusions:
We found that the current treatment regimen for childhood MDR-TB has significant psychological, academic, and financial impacts on children and their families. There is a need for psychosocial support of children and caregivers to mitigate the negative effects of community stigma, and to manage the stressors associated with chronic illness.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Mechanism of Antibiotic Resistance in MRSA
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

